INDV:NASDAQ
Indivior Pharmaceuticals Inc
$35.71
arrow_upward
+0.93%(+0.33) 1D
$35.71
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 2, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INDV...
Open
$35.46
High
$36.15
Low
$35.26
Mkt. cap
4.21B
Avg. vol.
1.97M
Volume
1.65M
P/E ratio
12.85
52-wk high
$42.81
52-wk low
$22.56
EPS
$2.78
Beta
1.10
Shares outstanding
118.03M
No. of employees
833
Open
$35.46
High
$36.15
Low
$35.26
Mkt. cap
4.21B
Avg. vol.
1.97M
Volume
1.65M
P/E ratio
12.85
52-wk high
$42.81
52-wk low
$22.56
EPS
$2.78
Beta
1.10
Shares outstanding
118.03M
No. of employees
833
News stories
From web sources and news partners
AD HOC NEWS
·
8 hours ago
Indivior declares USD 8.13 dividend. Indivior stock gains 1.27 percent
Profile
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market. Wikipedia
About Indivior Pharmaceuticals Inc
CEOMark Crossley
Employees833
FoundedSep 26, 2014
Headquarters-
SectorPharmaceutical industry
Websiteindivior.com